H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Balchem (BCPC) to $180 from $190 and keeps a Buy rating on the shares following the Q1 repot. The company’s base business appears relatively resistant to macro pressures, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCPC: